Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for patients who suffer side effects from common cholesterol pills

NCT ID NCT05923281

Completed Disease control Sponsor: Kowa Company, Ltd. Source: ClinicalTrials.gov ↗

Summary

This study tested a new medication called K-877 (pemafibrate) for people with high cholesterol who cannot tolerate standard statin drugs due to side effects. It involved 71 adult patients who took either a low dose, a higher dose, or a placebo pill for 12 weeks. The goal was to see if the new drug could safely lower 'bad' cholesterol (LDL-C) in this specific group.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Affiliated CENTRAL CLINIC of Higashiyamato Hospital

    Tokyo, Japan

  • Central Japan International Medical Center

    Gifu, Japan

  • Fukuwa Clinic

    Tokyo, Japan

  • Juntendo University Hospital

    Tokyo, Japan

  • Kohnodai Hospital, National Center for Global Health and Medicine

    Chiba, Japan

  • Koshigaya Municipal Hospital

    Saitama, Japan

  • Kumamoto University Hospital

    Kumamoto, Japan

  • Medical Corporation Chiseikai Tokyo Center Clinic

    Tokyo, Japan

  • Medical Corporation LONGWOOD Maeda Clinic

    Osaka, Japan

  • Mishuku Hospital

    Tokyo, Japan

  • NTT Medical Center Sapporo

    Hokkaido, Japan

  • Nakayama Clinic

    Aichi, Japan

  • OCROM Clinic

    Osaka, Japan

  • Rinku General Medical Center

    Osaka, Japan

  • Saitama Medical University Hospital

    Saitama, Japan

  • Seiwa Clinic

    Tokyo, Japan

  • Tashiro Endocrinology Clinic

    Fukuoka, Japan

  • ToCROM Clinic

    Tokyo, Japan

  • Tokyo Heart Summit Tokyo Heart Rhythm Hospital

    Tokyo, Japan

  • Tokyo-Eki Center-building Clinic

    Tokyo, Japan

  • Tsukuba Medical Center Foundation Tsukuba Medical Center Hospital

    Ibaraki, Japan

  • Yokohama Minami Kyosai Hospital

    Kanagawa, Japan

Conditions

Explore the condition pages connected to this study.

HYPERCHOLESTEROLEMIA